New developments in Helicobacter pylori eradication therapy

Scandinavian Journal of Gastroenterology, Supplement

Volumn 32, Issue 223, 1997, Pages 43-45

  Pounder, R E ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Amoxycillin; citrate; Clarithromycin; Eradication; H. pylori; Metronidazole; Ranitidine bismuth

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; STOMACH SECRETION INHIBITOR; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; RANITIDINE;

BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; DUODENUM ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; STOMACH ACID SECRETION; ULCER HEALING; DRUG COMBINATION; HELICOBACTER INFECTION; MICROBIOLOGY; REVIEW;

ANTI-BACTERIAL AGENTS; BISMUTH; DRUG THERAPY, COMBINATION; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTAMINE H2 ANTAGONISTS; HUMANS; RANITIDINE;

EID: 0030626442     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Marshall BJ. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; ii:1437-42.
2. Rauws EAJ, Tytgat GNJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990;535:1233-6.
3. Graham DY, et al. Effective treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. Ann Int Med 1992;116:730-4.
4. Gorbach SL. Bismuth therapy in gastrointestinal disease. Gastroenterology 1990;99:863-75.
5. Brinton W. Royal Free Hospital: ulcer of the stomach treated successfully. Ass Med J;1855:1125-6.
6. Wieriks J, Hespe W, Jaitly KD, Koekkoek PH, Lavy U. Pharmacological properties of colloidal bismuth subcitrate. Scand J Gastroenterol 1982;17:11-6.
7. Nwokolo CU, Lewis JF, Hudson M, Pounder RE. Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology 1992;102:163-7.
8. Gavey C, Szeto M-L, Nwokolo C, Sercombe J, Pounder RE. Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate. Aliment Pharmacol Ther 1989;3:21-8.
9. Nwokolo CU, Gavey CJ, Smith JTL, Pounder RE. The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Aliment Pharmacol Ther 1989;3:29-40.
10. 2-blockade on bismuth absorption from three ulcer-healing compounds. Gastroenterology 1991;101:889-94.
11. Nwokolo CU, Mistry P, Pounder RE. The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate). Aliment Pharmacol Ther 1990;4:163-70.
12. Nwokolo CU, Prewett EJ, Sawyerr AM, Pounder RE. Lack of bismuth absorption from bismuth subnitrate (Roter) tablets. Eur J Gastroenterol Hepatol 1990;2:433-5.
13. Chiba N, Rao BV, Rademaker JW, Hunt RH. Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterol 1992;87:1716-27.
14. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-69.
15. Penston JG. Helicobacter pylori eradication-understandable caution but no excuse for inertia [review article]. Aliment Pharmacol Ther 1994;8:369-90.
16. Hentschel E, Brandstatter G, Dragosics B, Hirschl AM, Nemec H, Schutze K, Taufer M, Wurzer H. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-12.
17. Lind T, Veldhuyzen van Zanten SJO, Unge P, Spiller RC, Bayerdorffer E, O'Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 study. Helicobacter 1996;1:138-44.
18. 2-antagonist activity, on 24-hour intragastric acidity. Aliment Pharmacol Ther 1991;5:481-90.
19. Stables R, Campbell CJ, Clayton NM, et al. Gastric anti-secretory, mucosal protective, anti-pepsin and anti-Helicobacter properites of ranitidine bismuth citrate. Aliment Pharmacol Ther 1993;7:237-46.
20. Bardhan KD, Dekkers CPM, Nowak A, et al. GR122311X (ranitidine bismuth citrate) a new drug for the treatment of duodenal ulcer. Aliment Pharmacol Ther 1995;9:497-506.
21. Logan RPH, Gummett PA, Misiewicz JJ, et al. The efficacy of ranitidine bismuth citrate (GR122311X) in the treatment of Helicobacter pylori infection. Gastroenterology 1992;102 (part 2):A114.
22. Wyeth JW, Pounder RE, Duggan AE, O'Morain CA, Schaufelberger HD, de Koster EH, et al. The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996;10:623-30.
23. Peterson WL. Ranitidine bismuth citrate and clarithromycin in ulcer disease. Aliment Pharmacol Ther 1996;10:251-61.
24. Bardhan KD, Dallaire C, Eisold H, Duggan AE. The treatment of duodenal ulcer with GR122311X (ranitidine bismuth citrate) and clarithromycin. Gut 1995;37 Suppl 1:A5.
25. Pounder RE, Bailey R, Louw JA, Ohlin B, Dixon MF, Quirke P, Duggan AE. GR122311X (ranitidine bismuth citrate) with clarithromycin eradication of Helicobacter pylori. Gut 1995;37 Suppl 1:A42.
26. Axon ATR, Ireland A, Lancaster-Smith MJ, Rooprams PD. Ranitidine bismuth citrate and clarithromycin twice daily in the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1997:81-5.
27. Bardhan KD, Wurzer H, Marcelino M, Jahnsen J, Lotay N. High cure rates with ranitidine bismuth citrate (Pylorid) plus clarithromycin given twice daily. Gut 1996;39 Suppl 2:A36.